What is the stage of your prod­uct fam­i­ly with­in the life cycle 

What lev­el of mar­ket­ing bud­get is avail­able for your prod­uct solution? 

Are port­fo­lio expan­sions or addi­tion­al indi­ca­tions planned to com­plete (or enhance) the cur­rent solution? 

What state­ment best describes the vol­ume of pub­lished data with­in the sci­en­tif­ic med­ical community? 

What state­ment best describes the fre­quen­cy of pub­lished data? 

What is the plan for future pub­li­ca­tions activity? 

How well do you know the rel­e­vant KOLs with­in your treatment/application area? 

Which state­ment most accu­rate­ly describes the sta­tus of rela­tion­ships with­in the KOL community? 

Which state­ment most accu­rate­ly describes the sta­tus of activ­i­ty planning? 

Which state­ment most accu­rate­ly describes the per­cep­tions and lev­el of mes­sage support? 

Which state­ment best describes the sit­u­a­tion of your tar­get market/customer?

What is the cur­rent sta­tus of the mes­sage platform? 

What degree of dif­fer­en­ti­a­tion is pos­si­ble with­in your treatment/application area? 

To what extent are you active at inter­na­tion­al, region­al and nation­al congresses? 

To what extent are you active at inter­na­tion­al con­gress­es with regard to abstract and poster submissions? 

What state­ment best describes your activ­i­ty lev­el and com­mit­ment with med­ical advi­so­ry boards? 

To what extent is your solu­tion part of med­ical training? 

What is the cur­rent sit­u­a­tion of reim­burse­ment in your major markets? 

What state­ment best describes the cur­rent sit­u­a­tion in regard to your val­ue demonstration? 

How active­ly do you focus on treat­ment protocols/pathways and Patient Report­ed Out­come Mea­sures (PROMs)?